Company profile: Molecular Assemblies
1.1 - Company Overview
Company description
- Provider of proprietary Fully Enzymatic Synthesis (FES) technology to produce long, pure, accurate DNA up to 400 nucleotides without post-synthesis purification; custom DNA oligos for CRISPR, cloning and NGS; gene editing, protein engineering and gene assembly services; and a partnering program licensing FES for on-site synthesis with an automated platform, proprietary reagents and research-use licenses.
Products and services
- Fully Enzymatic Synthesis (FES) Technology: Proprietary enzymatic DNA synthesis that constructs long, pure, accurate sequences up to 400 nucleotides and eliminates the need for post-synthesis purification
- Partnering Program: Research-use-only licensing that supplies an automated synthesis platform, proprietary reagents, and necessary licenses for on-site FES-based DNA synthesis at partner facilities
- Custom DNA Oligos: Custom-engineered single-stranded oligonucleotides up to 400 nucleotides, suitable for CRISPR gene editing, molecular cloning, and next-generation sequencing probes and controls
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Molecular Assemblies
Nightingale Health
HQ: Finland
Website
- Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nightingale Health company profile →
Constellation Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel therapeutics in the emerging field of epigenetics, focusing on selective regulators of epigenetic function critical to controlling gene expression; the first biopharmaceutical company dedicated to this area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Constellation Pharmaceuticals company profile →
BC Platforms
HQ: Switzerland
Website
- Description: Provider of data and technology platforms for life sciences and healthcare, enabling access, management, and analysis of clinical, genomic, and omics data. Offers a federated Global Data Network, secure data environments, analytics and AI/federated analytics, and scientific services supporting pharmaceutical research, clinical trials, and real-world data studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BC Platforms company profile →
Sangamo Therapeutics
HQ: United States
Website
- Description: Provider of engineered DNA-binding protein-based therapeutics, conducting clinical trials of gene and cell therapy candidates including: giroctocogene fitelparvovec for hemophilia A; ST-920 for Fabry disease; TX200 for patients undergoing a kidney transplant; SB-525/giroctocogene fitelparvovec (Phase 1/2); and BIVV003 ex vivo cell therapy for severe sickle cell disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sangamo Therapeutics company profile →
BioFluidica
HQ: United States
Website
- Description: Provider of a biotechnology diagnostic platform and automated liquid biopsy microfluidic system to isolate and enrich rare biomarkers—circulating tumor cells, exosomes, and trophoblasts—from body fluids; offers exosome and CTC isolation for research and cbNIPT, plus the B³ Blood Collection Tube for room-temperature whole blood shipping with buffer to inhibit micro-clotting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioFluidica company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Molecular Assemblies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Molecular Assemblies
2.2 - Growth funds investing in similar companies to Molecular Assemblies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Molecular Assemblies
4.2 - Public trading comparable groups for Molecular Assemblies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →